Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma. [electronic resource]
Producer: 20080908Description: 4859-68 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- pharmacology
- Base Pair Mismatch
- Brain Neoplasms -- drug therapy
- DNA Mismatch Repair
- Dacarbazine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Female
- Glioblastoma -- genetics
- Glioma -- drug therapy
- Humans
- Male
- Middle Aged
- O(6)-Methylguanine-DNA Methyltransferase -- genetics
- Temozolomide
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.